Last checked at 12 Jan 2011 08:20
For immediate release | 12 January 2011 |
Oxford BioMedica Plc
Notification of Major Interest in Shares
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: |
Oxford BioMedica Plc | ||
2. Reason for notification (yes/no) | |||
An acquisition or disposal of voting rights | Yes | ||
An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | |||
An event changing the breakdown of voting rights | |||
Other (please specify): | |||
3. Full name of person(s) subject to notification obligation: |
JP Morgan Asset Management Holdings Inc.
| ||
4. Full name of shareholder(s) (if different from 3): |
JP Morgan Asset Management UK Limited
| ||
5. Date of transaction (and date on which the threshold is crossed or reached if different): |
10 January 2011 | ||
6. Date on which issuer notified: |
11 January 2011 | ||
7. Threshold(s) that is/are crossed or reached: |
5% upwards | ||
8: Notified Details | |||||||
A: Voting rights attached to shares
| |||||||
Class/type of shares If possible use ISIN code
| Situation previous to the triggering transaction | Resulting situation after the triggering transaction
| |||||
Number of shares
| Number of voting rights
| Number of shares
| Number of voting rights | Percentage of voting rights | |||
Direct |
Indirect |
Direct |
Indirect | ||||
GB0006648157
| N/a | N/a | 83,733,144 | 8.86% | |||
B: Financial Instruments
| ||||
Resulting situation after the triggering transaction
| ||||
Type of financial instrument | Expiration date | Exercise/ conversion period/date | No. of voting rights that may be acquired (if the instrument exercised/converted) | Percentage of voting rights |
| ||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
| ||||
Resulting situation after the triggering transaction
| ||||
Type of financial instrument | Expiration date | Exercise/ conversion period/date | No. of voting rights that may be acquired (if the instrument exercised/converted) | Percentage of voting rights |
| ||||
Total (A+B+C)
| |
Number of voting rights | Percentage of voting rights |
83,733,144 | 8.86% |
9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable: |
JP Morgan Asset Management UK Limited 83,833,144 (8.86%) |
Proxy Voting: | |
10. Name of proxy holder:
| |
11. Number of voting rights proxy holder will cease to hold:
| |
12. Date on which proxy holder will cease to hold voting rights:
| |
13. Additional information:
| . |
14 Contact name:
| Andrew Wood |
15. Contact telephone name:
| 01865 783000 |